John Joyal
20Patents
9h-index
8Co-inventors
64Inventor score
Filing activity: Jan 8, 2009 → Dec 21, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8211401B2 | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA | Chemistry; Metallurgy | 66 | Active |
| US8962799B2 | Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereof | Chemistry; Metallurgy | 54 | Active |
| US8926944B2 | Radiolabeled prostate specific membrane antigen inhibitors | Chemistry; Metallurgy | 51 | Active |
| US8211402B2 | CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer | Chemistry; Metallurgy | 42 | Active |
| US8877970B2 | Inhibitors of carbonic anhydrase IX | Chemistry; Metallurgy | 32 | Active |
| US8840865B2 | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof | Chemistry; Metallurgy | 29 | Active |
| US8562945B2 | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof | Chemistry; Metallurgy | 28 | Active |
| US9687572B2 | PSMA-targeted dendrimers | Human Necessities | 28 | Active |
| US9447121B2 | Triazine based radiopharmaceuticals and radioimaging agents | Chemistry; Metallurgy | 9 | Active |
| US9388144B2 | Radiolabeled prostate specific membrane antigen inhibitors | Chemistry; Metallurgy | 7 | Active |
| US9956305B2 | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer | Human Necessities | 7 | Active |
| US9433594B2 | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US9120837B2 | Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX | Chemistry; Metallurgy | 5 | Active |
| US10201624B2 | Triazine based radiopharmaceuticals and radioimaging agents | Chemistry; Metallurgy | 2 | Active |
| US10086096B2 | Triazine based radiopharmaceuticals and radioimaging agents | Chemistry; Metallurgy | 2 | Active |
| US10898598B2 | Triazine based radiopharmaceuticals and radioimaging agents | Chemistry; Metallurgy | 1 | Active |
| US9422251B2 | Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX | Chemistry; Metallurgy | 0 | Active |
| US11167049B2 | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer | Human Necessities | 0 | Active |
| US11712485B2 | Triazine based radiopharmaceuticals and radioimaging agents | Chemistry; Metallurgy | 0 | Active |
| US10668174B2 | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.